Ono Pharmaceutical Co., Ltd. (OPHLF)
16.00
+0.84
(+5.54%)
USD |
OTCM |
Oct 26, 16:00
Ono Pharmaceutical Enterprise Value : 6.914B for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 6.914B |
| October 23, 2026 | 6.520B |
| October 22, 2026 | 6.520B |
| October 21, 2026 | 6.520B |
| October 20, 2026 | 6.520B |
| October 19, 2026 | 6.520B |
| October 16, 2026 | 6.520B |
| October 15, 2026 | 6.421B |
| October 14, 2026 | 6.421B |
| October 13, 2026 | 6.421B |
| October 12, 2026 | 6.421B |
| October 09, 2026 | 6.421B |
| October 08, 2026 | 6.421B |
| October 07, 2026 | 6.421B |
| October 06, 2026 | 6.421B |
| October 05, 2026 | 6.421B |
| October 02, 2026 | 6.421B |
| October 01, 2026 | 6.421B |
| September 30, 2026 | 6.421B |
| September 29, 2026 | 6.585B |
| September 28, 2026 | 6.585B |
| September 25, 2026 | 6.966B |
| September 24, 2026 | 6.966B |
| September 23, 2026 | 6.966B |
| September 22, 2026 | 6.045B |
| Date | Value |
|---|---|
| September 21, 2026 | 6.045B |
| September 18, 2026 | 6.444B |
| September 17, 2026 | 6.444B |
| September 16, 2026 | 6.444B |
| September 15, 2026 | 6.444B |
| September 14, 2026 | 6.444B |
| September 11, 2026 | 6.444B |
| September 10, 2026 | 6.444B |
| September 09, 2026 | 6.444B |
| September 08, 2026 | 6.416B |
| September 04, 2026 | 6.416B |
| September 03, 2026 | 6.416B |
| September 02, 2026 | 7.149B |
| September 01, 2026 | 6.237B |
| August 31, 2026 | 6.632B |
| August 28, 2026 | 6.632B |
| August 27, 2026 | 6.849B |
| August 26, 2026 | 6.849B |
| August 25, 2026 | 6.849B |
| August 24, 2026 | 6.916B |
| August 21, 2026 | 6.914B |
| August 20, 2026 | 6.914B |
| August 19, 2026 | 6.759B |
| August 18, 2026 | 6.308B |
| August 17, 2026 | 6.308B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 92.14B |
| Daiichi Sankyo Co., Ltd. | 31.72B |
| Eisai Co., Ltd. | 9.067B |
| Chugai Pharmaceutical Co., Ltd. | 65.89B |
| Santen Pharmaceutical Co., Ltd. | 3.361B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 151.63M |
| Revenue (Quarterly) | 728.94M |
| Total Expenses (Quarterly) | 577.39M |
| EPS Diluted (Quarterly) | 0.3224 |
| Gross Profit Margin (Quarterly) | 75.31% |
| Profit Margin (Quarterly) | 20.80% |
| Earnings Yield | 6.60% |